Adenovirus

Industry

CPC
A61K35/761

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

AHUMAN NECESSITIES A61Medical science A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Current Industry

A61K35/761Adenovirus

Industries

Patents Grantslast 30 patents

Information Patent Grant
Modified adenoviruses
- Patent number 12,318,418
- Issue date Jun 3, 2025
- University College Cardiff Consultants Limited
- Alan Parker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods of treating ocular diseases
- Patent number 12,310,997
- Issue date May 27, 2025
- The Regents of the University of California
- David V. Schaffer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Therapeutic pharmaceutical composition for bone and soft tissue tumors
- Patent number 12,310,998
- Issue date May 27, 2025
- Surv BioPharma Inc.
- Ken-ichiro Kosai
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant adenoviruses and uses thereof
- Patent number 12,312,382
- Issue date May 27, 2025
- Beth Israel Deaconess Medical Center, Inc.
- Dan H. Barouch
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Personalized cancer vaccines
- Patent number 12,295,976
- Issue date May 13, 2025
- EpicentRx, Inc.
- Christopher Larson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Means and methods for AAV gene therapy in humans
- Patent number 12,285,451
- Issue date Apr 29, 2025
- Uniqure IP B.V.
- Bart Antonius Nijmeijer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Combination comprising HDAC inhibitor and CD137 agonist for cancer...
- Patent number 12,285,410
- Issue date Apr 29, 2025
- 4SC AG
- Svetlana Hamm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant adenoviruses carrying transgenes
- Patent number 12,280,123
- Issue date Apr 22, 2025
- EpicentRx, Inc.
- Christopher Larson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for enhanced gene expression in cone cells
- Patent number 12,275,959
- Issue date Apr 15, 2025
- Adverum Biotechnologies, Inc.
- Thomas W. Chalberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Therapeutic agent for neurodegenerative disease
- Patent number 12,268,729
- Issue date Apr 8, 2025
- Toru Miyazaki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Adeno-associated virus virions for treatment of epilepsy
- Patent number 12,263,231
- Issue date Apr 1, 2025
- Jichi Medical University
- Shin-ichi Muramatsu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Adenovirus armed with bispecific T cell engager
- Patent number 12,258,417
- Issue date Mar 25, 2025
- AKAMIS BIO LIMITED
- Brian Robert Champion
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Adeno-associated virus purification methods
- Patent number 12,246,047
- Issue date Mar 11, 2025
- Takeda Pharmaceutical Company Limited
- Christian Fiedler
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oncolytic virus or antigen presenting cell mediated cancer therapy...
- Patent number 12,239,666
- Issue date Mar 4, 2025
- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. INC.
- Amer A. Beg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant replication competent viruses comprising a coding regio...
- Patent number 12,233,096
- Issue date Feb 25, 2025
- ORCA Therapeutics B.V.
- Wenliang Dong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Viral gene therapy as treatment for cholesterol storage disease or...
- Patent number 12,201,658
- Issue date Jan 21, 2025
- The United States of America, as represented by the Secretary, Department of...
- Charles P. Venditti
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Adeno-associated virus compositions for restoring PAH gene function...
- Patent number 12,203,094
- Issue date Jan 21, 2025
- HOMOLOGY MEDICINES, INC.
- Albert Barnes Seymour
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Adeno-associated virus compositions for restoring HBB gene function...
- Patent number 12,201,657
- Issue date Jan 21, 2025
- City of Hope
- Saswati Chatterjee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Tumor-selective E1a and E1b mutants
- Patent number 12,195,766
- Issue date Jan 14, 2025
- The Regents of the University of California
- Tony Reid
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of reducing neuronal microtubule binding protein Tau (Tau) l...
- Patent number 12,186,353
- Issue date Jan 7, 2025
- Adaerata, Limited Partnership
- Michel Cayouette
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapy strategy to restore electrical and cardiac function, a...
- Patent number 12,186,369
- Issue date Jan 7, 2025
- The Regents of the University of California
- Farah Sheikh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapy for ciliopathies
- Patent number 12,171,794
- Issue date Dec 24, 2024
- UCL BUSINESS LTD
- Philip Beales
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for CNS delivery of arylsulfatase A
- Patent number 12,168,041
- Issue date Dec 17, 2024
- Takeda Pharmaceutical Company Limited
- Nazila Salamat-Miller
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for CNS delivery of heparan N-sulfatase
- Patent number 12,161,702
- Issue date Dec 10, 2024
- Takeda Pharmaceutical Company Limited
- Farah Natoli
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinantly-modified adeno-associated virus (rAAV) having improve...
- Patent number 12,156,894
- Issue date Dec 3, 2024
- Charles River Laboratories, Inc.
- Qizhao Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Adenoviruses and methods for using adenoviruses
- Patent number 12,139,726
- Issue date Nov 12, 2024
- Mayo Foundation for Medical Education and Research
- Michael A. Barry
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oncolytic adenoviruses for treating cancer
- Patent number 12,129,280
- Issue date Oct 29, 2024
- FUNDACIÓ INSTITUT D'INVESTIGACIÓ BIOMEDICA DE BELLVITGE
- Sònia Guedan Carrió
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for CNS delivery of iduronate-2-sulfatase
- Patent number 12,121,569
- Issue date Oct 22, 2024
- Takeda Pharmaceutical Company Limited
- Gaozhong Zhu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Butyrylcholinesterases having an enhanced ability to hydrolyze acyl...
- Patent number 12,116,602
- Issue date Oct 15, 2024
- Mayo Foundation for Medical Education and Research
- Liyi Geng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of treating solid or lymphatic tumors by combination therapy
- Patent number 12,090,183
- Issue date Sep 17, 2024
- CG ONCOLOGY, INC.
- Alex Wah Hin Yeung
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)
- Publication number 20250171745
- Publication date May 29, 2025
- DNATRIX, INC.
- Frank TUFARO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR...
- Publication number 20250161383
- Publication date May 22, 2025
- The United States of America, As Represented by the Secretary, Department of...
- Charles P. Venditti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MICRO-DYSTROPHIN TO TREAT...
- Publication number 20250161490
- Publication date May 22, 2025
- Research Institute at Nationwide Children's Hospital
- Louise Rodino-Klapac
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A
- Publication number 20250161417
- Publication date May 22, 2025
- Takeda Pharmaceutical Company Limited
- Nazila Salamat-Miller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NASAL ANTI-CANCER THERAPIES
- Publication number 20250152642
- Publication date May 15, 2025
- ORGENESIS INC.
- Oren Moskovich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
A GENE THERAPY STRATEGY TO RESTORE ELECTRICAL AND CARDIAC FUNCTION,...
- Publication number 20250127854
- Publication date Apr 24, 2025
- The Regents of the University of California
- Farah Shiekh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE
- Publication number 20250121040
- Publication date Apr 17, 2025
- Takeda Pharmaceutical Company Limited
- Gaozhong Zhu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITION AND METHODS FOR MODULATION OF ELOVL2
- Publication number 20250099553
- Publication date Mar 27, 2025
- YouHealth Biotech, Limited
- Kang ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTICANCER COMPOSITION COMPRISING RECOMBINANT ADENOVIRUS EXPRESSING...
- Publication number 20250082702
- Publication date Mar 13, 2025
- Genemedicine Co., Ltd.
- Chae Ok YUN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT AAV FOR THE GENE THERAPY OF FABRY DISEASE
- Publication number 20250066812
- Publication date Feb 27, 2025
- Skyline Therapeutics Limited
- Jinzhao HOU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPY FOR CILIOPATHIES
- Publication number 20250057899
- Publication date Feb 20, 2025
- UCL Business LTD
- Philip Beales
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES
- Publication number 20250027058
- Publication date Jan 23, 2025
- Mayo Foundation for Medical Education and Research
- Michael A. Barry
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ADENOVIRUS ARMED WITH BISPECIFIC T CELL ACTIVATOR
- Publication number 20250026851
- Publication date Jan 23, 2025
- AKAMIS BIO LIMITED
- Brian Robert CHAMPION
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ONCOLYTIC ADENOVIRUSES FOR TREATING CANCER
- Publication number 20250011373
- Publication date Jan 9, 2025
- FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE (IDIBELL)
- Sònia Guedan Carrió
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
AAV-MEDIATED GENE TRANSFER FOR RETINOPATHY
- Publication number 20240424039
- Publication date Dec 26, 2024
- OCULOGENEX INC.
- Hema Lakshmi Ramkumar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GROUP B ADENOVIRUS-CONTAINING FORMULATION
- Publication number 20240398879
- Publication date Dec 5, 2024
- AKAMIS BIO LIMITED
- Simon ALVIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE CELL TARGETING USING ADENOVIRUS AND CHEMICAL DIMERS
- Publication number 20240342231
- Publication date Oct 17, 2024
- Salk Institute for Biological Studies
- Clodagh O'Shea
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASE
- Publication number 20240325571
- Publication date Oct 3, 2024
- Christopher Key
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ONCOLYTIC ADENOVIRUSES ARMED WITH HETEROLOGOUS GENES
- Publication number 20240325472
- Publication date Oct 3, 2024
- AKAMIS BIO LIMITED
- Brian Robert CHAMPION
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MEMBRANE LIPID COATED NANOPARTICLES AND METHOD OF USE
- Publication number 20240325314
- Publication date Oct 3, 2024
- Coastar Therapeutics Inc.
- Eddie Yocon Chung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Adenoviral Vector
- Publication number 20240301443
- Publication date Sep 12, 2024
- OXFORD UNIVERSITY INNOVATION LIMITED
- Sarah C. Gilbert
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SELECTIVE STIMULATION OF T CELLS IN SOLID TUMORS USING ONCOLYTIC VI...
- Publication number 20240299541
- Publication date Sep 12, 2024
- The Trustees of the University of Pennsylvania
- Mikko Siurala
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
3-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE TH...
- Publication number 20240293458
- Publication date Sep 5, 2024
- Nurix Therapeutics, Inc.
- Arthur T. SANDS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOEVASIVE ANTI-TUMOR ADENOVIRUS
- Publication number 20240293487
- Publication date Sep 5, 2024
- Jin-Woo CHOI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR ACHIEVING HIGH LEVELS OF TRANSDUCTION...
- Publication number 20240294941
- Publication date Sep 5, 2024
- The Trustees of the University of Pennsylvania
- James M. Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RECOMBINANT ADENOVIRUSES AND USES THEREOF
- Publication number 20240287142
- Publication date Aug 29, 2024
- Beth Israel Deaconess Medical Center, Inc.
- Dan H. BAROUCH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADENOVIRUS FOR ANTI-TUMOUR THERAPY
- Publication number 20240261350
- Publication date Aug 8, 2024
- Medizinische Hochschule Hannover
- Florian Kühnel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC PHARMACEUTICAL COMPOSITION FOR BONE AND SOFT TISSUE TUMORS
- Publication number 20240252561
- Publication date Aug 1, 2024
- Surv BioPharma Inc.
- Ken-ichiro KOSAI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF HEAT INACTIVATION OF ADENOVIRUS
- Publication number 20240252562
- Publication date Aug 1, 2024
- ULTRAGENYX PHARMACEUTICAL INC.
- Christopher J. Morrison
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GROUP B ADENOVIRUS ENCODING AN ANTI-TCR-COMPLEX ANTIBODY OR FRAGMENT
- Publication number 20240247061
- Publication date Jul 25, 2024
- AKAMIS BIO LIMITED
- Brian Robert CHAMPION
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Modified adenoviruses

Compositions and methods of treating ocular diseases

Therapeutic pharmaceutical composition for bone and soft tissue tumors

Recombinant adenoviruses and uses thereof

Personalized cancer vaccines

Means and methods for AAV gene therapy in humans

Combination comprising HDAC inhibitor and CD137 agonist for cancer...

Recombinant adenoviruses carrying transgenes

Compositions and methods for enhanced gene expression in cone cells

Therapeutic agent for neurodegenerative disease

Adeno-associated virus virions for treatment of epilepsy

Adenovirus armed with bispecific T cell engager

Adeno-associated virus purification methods

Oncolytic virus or antigen presenting cell mediated cancer therapy...

Recombinant replication competent viruses comprising a coding regio...

Viral gene therapy as treatment for cholesterol storage disease or...

Adeno-associated virus compositions for restoring PAH gene function...

Adeno-associated virus compositions for restoring HBB gene function...

Tumor-selective E1a and E1b mutants

Method of reducing neuronal microtubule binding protein Tau (Tau) l...

Gene therapy strategy to restore electrical and cardiac function, a...

Gene therapy for ciliopathies

Methods and compositions for CNS delivery of arylsulfatase A

Methods and compositions for CNS delivery of heparan N-sulfatase

Recombinantly-modified adeno-associated virus (rAAV) having improve...

Adenoviruses and methods for using adenoviruses

Oncolytic adenoviruses for treating cancer

Methods and compositions for CNS delivery of iduronate-2-sulfatase

Butyrylcholinesterases having an enhanced ability to hydrolyze acyl...

Methods of treating solid or lymphatic tumors by combination therapy

Patents Applicationslast 30 patents

ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)

VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR...

ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MICRO-DYSTROPHIN TO TREAT...

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A

NASAL ANTI-CANCER THERAPIES

A GENE THERAPY STRATEGY TO RESTORE ELECTRICAL AND CARDIAC FUNCTION,...

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE

COMPOSITION AND METHODS FOR MODULATION OF ELOVL2

ANTICANCER COMPOSITION COMPRISING RECOMBINANT ADENOVIRUS EXPRESSING...

RECOMBINANT AAV FOR THE GENE THERAPY OF FABRY DISEASE

GENE THERAPY FOR CILIOPATHIES

ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES

ADENOVIRUS ARMED WITH BISPECIFIC T CELL ACTIVATOR

ONCOLYTIC ADENOVIRUSES FOR TREATING CANCER

AAV-MEDIATED GENE TRANSFER FOR RETINOPATHY

GROUP B ADENOVIRUS-CONTAINING FORMULATION

SELECTIVE CELL TARGETING USING ADENOVIRUS AND CHEMICAL DIMERS

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASE

ONCOLYTIC ADENOVIRUSES ARMED WITH HETEROLOGOUS GENES

MEMBRANE LIPID COATED NANOPARTICLES AND METHOD OF USE

Adenoviral Vector

SELECTIVE STIMULATION OF T CELLS IN SOLID TUMORS USING ONCOLYTIC VI...

3-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE TH...

IMMUNOEVASIVE ANTI-TUMOR ADENOVIRUS

COMPOSITIONS AND METHODS FOR ACHIEVING HIGH LEVELS OF TRANSDUCTION...

RECOMBINANT ADENOVIRUSES AND USES THEREOF

ADENOVIRUS FOR ANTI-TUMOUR THERAPY

THERAPEUTIC PHARMACEUTICAL COMPOSITION FOR BONE AND SOFT TISSUE TUMORS

METHODS OF HEAT INACTIVATION OF ADENOVIRUS

GROUP B ADENOVIRUS ENCODING AN ANTI-TCR-COMPLEX ANTIBODY OR FRAGMENT